Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Advanced Soft Tissue Sarcoma
NCT00003718Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in soft tissue sarcoma (STS), sponsored by Herbert Irving Comprehensive Cancer Center. Status: unknown.
02
Drugs
temozolomide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00003718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003718.